Business
from24/7 Wall St.
1 day agoModerna and Ross Stores Lead Stock Gainers on Wednesday
Moderna surges 8.9% after settling a $2.25 billion patent dispute with Arbutus and Genevant over lipid nanoparticle technology, eliminating future royalty obligations and litigation risks for its mRNA pipeline.